Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb double-blind study of orodispersible vardenafil versus placebo in erectile dysfunction with comorbidity
2009-017686-34Phase 3Completed
- Sponsor
- UROLOGY ASSOCIATES S.L.
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Vardenafil orodispersible tablet with Placebo (2 arms). Primary endpoints: Change in IIEF-EF score and Change in erection duration. Started Feb 2010; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2009-017686-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017686-34.